Supply, Storage, Over-labelling and Distribution of Ascorbic Acid
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 |
| Deadline | 16 Apr 2021 |
| Contract start | 20 Apr 2021 |
| Contract end | 30 Sept 2021 |
| Procedure | selective |
| SME suitable | No |
| OCID | ocds-b5fd17-e67b0e8f-fb13-46a2-863a-d4577d178f36 |
Awards (2)
This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is ·.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Clinigen Healthcare Limited shared | £76,932 | 20 Apr 2021 | active |
| Mawdsley- Brooks & Company Limited shared | £76,932 | 20 Apr 2021 | active |
description
The Department of Health and Social Care conducted a negotiated procedure without prior publication under the Public Contracts Regulations 2015 (as amended) for the Supply, Storage, Over-labelling and Distribution of Ascorbic Acid.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 15 Nov 2022 | Award update (awardUpdate) | · | ec58ba15-2d9b-43f8-9d04-6a49619205fa-590168 |
more from ATAMIS LTD
- Avon & Bedford Court 76-92 Church Street Weybridge, Surrey, KT13 8DL · £150,000 · 3 Mar 2026
- UKRI-5133 MRC LMB Microscope Servicing · £683,875 · 29 Aug 2025
- Assurance of SW's Management Approach Policies · £300,000 · 25 Nov 2024
- IFRS 16 lease valuations · £81,000 · 27 Sept 2024
- Microsoft Licences · £128,487 · 19 Sept 2024
- Programme Director Services · £92,575 · 19 Sept 2024
- Ward Boards software · £32,545 · 17 Sept 2024
- Carenotes- Right To Use- Licence · £319,923 · 16 Sept 2024
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.